Partnering & Licensing
For global licensing, co-development, and out-licensing discussions across our Phase 1+ pipeline.
[email protected]Subject: Partnering Inquiry
Contact
Contact GlycoNex
Email
Phone
+886-2-2697-4168
Headquarters
New Taipei City, Taiwan
Listing
TPEx:4168 (Taipei Exchange)
01 — Inquiry Routing
Choose the Right Channel
CDMO & Manufacturing
For antibody contract development, GMP-compliant manufacturing, and glycan analytical services.
[email protected]Subject: CDMO Inquiry
Investor Relations
For shareholders, analysts, and institutional investors.
[email protected]Subject: Investor Relations
Media & Press
For press, interviews, and media inquiries.
[email protected]Subject: Media Inquiry
02 — General & Headquarters
General Inquiries
For all other inquiries, email [email protected] — no subject line required. A subject line is only needed for the four channels above. GlycoNex responds in English and Traditional Chinese.
New Taipei City 221, Taiwan
Tel: +886-2-2697-4168
Email: [email protected]